United States Women Health Laboratory Testing Market is expected to be dominated by Cervical cancer type of hereditary cancer through 2028

Rising prevalence of infectious diseases and cancer in women is expected to drive the growth of the United States Women Health Laboratory Testing Market in the forecast period, 2018-2028

According to TechSci Research report, “United States Women Health Laboratory Testing Market - By Region, Competition Forecast and Opportunities, 2018-2028”, the United States Women Health Laboratory Testing Market is expected to register an impressive CAGR during the forecast period 2018-2028. The rise in prevalence of chronic diseases, growing awareness amongst the key market players regarding different women health problems and need to provide testing solutions, and recent developments to contribute to the growth of the United States women health laboratory testing market.

Furthermore, the advancement and research in technology and for developing new testing solutions for addressing different women health problems is expected to create lucrative opportunities for the growth of United States Women Health Laboratory Testing Market in the coming years.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Women Health Laboratory Testing Market”

United States Women Health Laboratory Testing Market can be segmented by hereditary cancer, reproductive health and infectious diseases, prenatal screening and diagnostic testing, region, and competitive landscape.

Based on hereditary cancer, the market is segmented into cervical cancer, ovarian cancer, and breast cancer. The cervical cancer segment is expected to show an impressive growth in forecast period due to the rising rate of this type of cancer amongst women.   

In terms of reproductive health and infectious diseases, the market can be split into CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing. The HIV Testing  segment is expected to show an impressive growth in forecast period due to the rising rate of AIDS among population. Also, increasing incidences of human papillomavirus in the country is expected to create new prospects for the growth of HPV testing segment in the coming years. According to Centers for Disease Control and Prevention, more than 42 million Americans are infected with types of HPV that cause disease.

Based on regional analysis, the market is divided into Mid-West, South, North-East, and West. The Mid-West region is expected to show an impressive growth in forecast period due to advanced healthcare facilities and growing expenditure in research and development in the region.

Major companies operating in United States Women Health Laboratory Testing Market include:

• F. Hoffmann-La Roche AG.
• Stanbio Laboratory L.P.
• Yourgene Health
• Myriad Genetics Inc.
• Natera, Inc.
• Ovia Health
• Laboratory Corporation of America Holdings, Inc.
• Gateway Genomics, LLC
• Ascension Healthcare Network Inc
• EKF Diagnostics Holdings Plc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“United States Women Health Laboratory Testing Market is expected to witness significant growth during the forecast period on account of increasing awareness for diagnostic procedures. An increase in number of cancer and chronic diseases further supports the demand for women health laboratory testing market in the United States. Additionally, increase in emergence of players developing new procedures of diagnostic and treatment is expected to create lucrative opportunities for the market growth in the next few years” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028”, has evaluated the future growth potential of United States Women Health Laboratory Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Women Health Laboratory Testing Market.